Clinical Significance and Management of Low C4 Levels

Initial Diagnostic Approach

The American College of Physicians recommends measuring C1INH antigen and functional levels immediately when C4 is low to distinguish between C1INH deficiency states and autoimmune causes, as at least 95% of patients with C1INH deficiency demonstrate reduced C4 levels even between attacks 1
Type I HAE presents with low C4 + low C1INH antigen + low C1INH function (<50-60% of normal), Type II HAE shows low C4 + normal C1INH antigen + low C1INH function, and Acquired C1INH deficiency demonstrates low C4 + low C1INH + low C1q levels, distinguishing it from hereditary forms 1
If C1INH deficiency is confirmed, immediately discontinue ACE inhibitors or ARBs as they are contraindicated, and recognize that traditional therapies are ineffective 1

The European League Against Rheumatism recommends measuring C4 alongside C3 at baseline in all SLE patients as part of the comprehensive autoantibody panel that includes ANA, anti-dsDNA, anti-Ro, anti-La, anti-RNP, anti-Sm, and anti-phospholipid antibodies 2, 3
Re-evaluate C3/C4 levels to support evidence of disease activity or remission, particularly when assessing treatment response or disease flares 2, 3

For patients with established lupus nephropathy, measure C3 and C4 alongside anti-dsDNA, urine protein/creatinine ratio, urine microscopy, and blood pressure at least every 3 months for the first 2-3 years 2, 3

Do not rely on C4 alone during active treatment, as C4 levels can normalize in patients already receiving therapy for autoimmune disease, requiring repeat testing during an acute attack or flare 1
Ensure timely laboratory processing, as C4 samples must be sent to the laboratory promptly to avoid artificially low results due to degradation 1